In addition, an integrated, quantitative immune cell and phenotype profile of AML patients reflects a poor prognosis with a high proportion of M1-polarized macrophages and FOXP3+ helper T-cells, with a similar outcome between bone marrow and peripheral blood samples (57). The gene discussed is FOXP3; the disease is acute myeloid leukemia.